Analystreport

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

MOMENTA PHARMACEUTICALS  (MNTA) 
Last momenta pharmaceuticals earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.momentapharma.com/investor-relations